Literature DB >> 17395694

Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.

Nitzan Levy1, Xiaoyue Zhao, Hui Tang, Robert B Jaffe, Terence P Speed, Dale C Leitman.   

Abstract

Estrogen receptors (ERs) regulate transcription by interacting with regulatory elements in target genes. However, known ER regulatory elements cannot explain the expression profiles of genes activated by estradiol (E2) and selective estrogen receptor modulators (SERMs). We previously showed that the killer cell lectin-like receptor (NKG2E) gene is regulated by E2, tamoxifen, and raloxifene. Here we used the NKG2E gene as a model to investigate the mechanism whereby target genes are regulated by E2 and SERMs with ERalpha. The ER regulatory element in the NKG2E promoter was mapped to the -1825 and -1686 region. Full activation of the NKG2E promoter required the collaboration between a transcription factor cluster containing c-jun, heat-shock factor 2, and CCAAT/enhancer-binding protein beta and a unique variant estrogen response element (ERE) that has only a two nucleotide spacer between half sites. The cluster elements and the variant ERE were inactive on their own, but the regulation by E2 and SERMs was restored when the c-jun, heat-shock factor-2, and CCAAT/enhancer-binding protein beta cluster was placed upstream of the variant ERE. The activation of the NKG2E gene by E2 and selective ER modulators was associated with the recruitment of the p160 coactivators glucocorticoid receptor-interacting protein 1 and amplified in breast cancer 1 but not steroid receptor coactivator 1. These studies identified one of the most complex ER regulatory units thus far reported and demonstrate that a cluster of flanking transcription factors collaborate with ER to induce a functional ERE in the NKG2E promoter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395694     DOI: 10.1210/en.2006-1632

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.

Authors:  Lonnele J Ball; Nitzan Levy; Xiaoyue Zhao; Chandi Griffin; Mary Tagliaferri; Isaac Cohen; William A Ricke; Terence P Speed; Gary L Firestone; Dale C Leitman
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

2.  Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1.

Authors:  Nabila Hamdaoui; Maryvonne Baudoin-Legros; Mairead Kelly; Abdel Aissat; Sandra Moriceau; Diane-Lore Vieu; Julien Colas; Janine Fritsch; Aleksander Edelman; Gabrielle Planelles
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  Estrogen receptors bind to and activate the HOXC4/HoxC4 promoter to potentiate HoxC4-mediated activation-induced cytosine deaminase induction, immunoglobulin class switch DNA recombination, and somatic hypermutation.

Authors:  Thach Mai; Hong Zan; Jinsong Zhang; J Seth Hawkins; Zhenming Xu; Paolo Casali
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

Review 4.  Regulation of specific target genes and biological responses by estrogen receptor subtype agonists.

Authors:  Dale C Leitman; Sreenivasan Paruthiyil; Omar I Vivar; Elise F Saunier; Candice B Herber; Isaac Cohen; Mary Tagliaferri; Terence P Speed
Journal:  Curr Opin Pharmacol       Date:  2010-10-14       Impact factor: 5.547

5.  Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.

Authors:  Nitzan Levy; Dierdre Tatomer; Candice B Herber; Xiaoyue Zhao; Hui Tang; Toby Sargeant; Lonnele J Ball; Jonathan Summers; Terence P Speed; Dale C Leitman
Journal:  Mol Endocrinol       Date:  2007-10-25

6.  Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist.

Authors:  Jennifer E Mersereau; Nitzan Levy; Richard E Staub; Scott Baggett; Tatjana Zogovic; Tetjana Zogric; Sylvia Chow; William A Ricke; Mary Tagliaferri; Isaac Cohen; Leonard F Bjeldanes; Dale C Leitman
Journal:  Mol Cell Endocrinol       Date:  2007-11-26       Impact factor: 4.102

7.  Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1.

Authors:  Wilbert Zwart; Mariska Rondaij; Kees Jalink; Z Dave Sharp; Michael A Mancini; Jacques Neefjes; Rob Michalides
Journal:  Mol Endocrinol       Date:  2009-05-28

8.  Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.

Authors:  Omar I Vivar; Elise F Saunier; Dale C Leitman; Gary L Firestone; Leonard F Bjeldanes
Journal:  Endocrinology       Date:  2010-02-16       Impact factor: 4.736

9.  Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.

Authors:  Fei Gu; Hang-Kai Hsu; Pei-Yin Hsu; Jiejun Wu; Yilin Ma; Jeffrey Parvin; Tim H-M Huang; Victor X Jin
Journal:  BMC Syst Biol       Date:  2010-12-17

10.  Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.

Authors:  Sreenivasan Paruthiyil; Aleksandra Cvoro; Xiaoyue Zhao; Zhijin Wu; Yunxia Sui; Richard E Staub; Scott Baggett; Candice B Herber; Chandi Griffin; Mary Tagliaferri; Heather A Harris; Isaac Cohen; Leonard F Bjeldanes; Terence P Speed; Fred Schaufele; Dale C Leitman
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.